Should we spend on new-patient ads or on recall first?

It's budget season, the practice wants growth, and the agency's proposal is on the desk. Before signing: compare the arithmetic of the two audiences, because they are not close.

The cost side

A new patient arrives through ad spend, landing pages, and the conversion odds of a stranger — practices commonly spend three figures per acquired patient before the first appointment. A recalled patient arrives through a text sequence to someone already in your system: the marginal cost rounds to zero. Same chair, same revenue, radically different acquisition price.

The conversion side

Strangers convert like strangers. In a live practice we measure, even that practice's own written-off leads closed at 67% once engaged — and lapsed patients are a warmer population than any lead: the relationship exists, the trust exists, the chart exists. When a quarter to a third of properly-recalled patients rebook, recall out-converts any cold campaign a practice can buy.

The arithmetic together

A practice with 42 patients due weekly and leaking recall can recover five figures monthly — at near-zero marginal cost — before a single ad dollar. The same five figures through ads costs the ad budget PLUS the conversion losses of cold traffic. Recall first isn't a philosophy; it's just the cheaper column in the spreadsheet.

The one case where ads win

A young practice without a patient base has no file to recall — ads and referral work ARE the right spend, because recall needs a past to work with. And a practice whose recall already runs at "Covered" has earned the right to pour into acquisition, knowing new patients enter a system that keeps them. The order of operations: build the retention machine, then buy the traffic — because acquisition into a leaking file is renting patients you could have owned.

Find out which case you are

The free score takes three minutes and shows whether your file is an asset or a leak. The $500 discovery measures the flow with timestamps. Then spend the budget wherever the evidence points — including on ads, if the evidence says so.